Molina Healthcare, Inc. (MOH) Stock Price, News, Analysis

Technical Score (1D)

BUY

News Sentiment

BULLISH

RBC Capital has just initiated coverage of Molina Healthcare with a sector‑perform recommendation, signaling fresh institutional confidence in the company’s business model. The new coverage is likely to shift investor sentiment and could prompt a reassessment of the stock’s valuation in the coming days. At the same time, RBC analysts have reiterated that Molina’s earnings‑growth trajectory through 2027 remains clear, even though Medicaid reimbursement rates pose a potential risk. The near‑term earnings visibility suggests that the company’s managed‑care contracts are expected to drive revenue expansion, providing a stable growth foundation. The juxtaposition of a positive coverage launch with the acknowledgment of Medicaid rate uncertainty creates a nuanced outlook that traders should interpret carefully. In the next 1–10 trading days, the market will likely react to any updates on the new coverage’s valuation assumptions and to the company’s forthcoming earnings guidance. Watch for the release of Molina’s next earnings report, which will reveal whether Medicaid rate adjustments materially affect revenue projections. Additionally, monitor any commentary from RBC on the valuation impact of the new coverage, as it could refine the upside potential. Finally, keep an eye on broader Medicaid policy developments that could influence reimbursement rates and, by extension, Molina’s profitability.

MOH|Company Info

Sector

Healthcare

Industry

Healthcare Plans

Exchange

NYQ

Country

United States

Website

molinahealthcare.com

Symbol

MOH

Description

Molina Healthcare is a managed care provider specializing in government-sponsored healthcare programs. The company primarily serves low-income populations, offering health plans through Medicaid and Medicare programs across the United States. Molina's value proposition centers on delivering accessible and affordable healthcare solutions to vulnerable communities. Operating through four key segments – Medicaid, Medicare, Marketplace, and Other – the company has established a presence in the healthcare market since its founding in 1980. Headquartered in Long Beach, California, Molina Healthcare focuses on providing essential healthcare services to individuals and families who qualify for government assistance.

MOH|Earnings Snapshot

Earnings Summary

Molina Healthcare is a managed‑care provider focused on Medicaid and Medicare programs, delivering affordable health plans to low‑income populations across the United States; it operates through Medicaid, Medicare, Marketplace, and Other segments within the broader healthcare plans sector. In the most recent quarters, revenue grew from $10.50 B in Q4 2024 to $11.15 B in Q1 2025 (+6.3%) and then to $11.43 B in Q2 2025 (+2.4%) before plateauing at $11.48 B in Q3 2025 (+0.4%) and slightly declining to $11.38 B in Q4 2025 (‑0.9% versus Q3); the company’s Q1 2026 revenue fell further to $10.80 B (‑5.2% versus Q4 2025). EPS performance has been mixed: the firm missed estimates in Q4 2024 (5.05 vs 5.88), beat them in Q1 2025 (6.08 vs 5.96), missed again in Q2 2025 (5.48 vs 5.53), and suffered significant misses in Q3 2025 (1.84 vs 3.89) and Q4 2025 (‑2.75 vs 0.34), before beating estimates again in Q1 2026 (2.35 vs 1.94). Over the past year, revenue has risen YoY by roughly 8.3% from Q4 2024 to Q4 2025, yet EPS has swung from a positive $5.05 to a negative ‑$2.75, indicating volatility in profitability despite steady top‑line growth. Recent news highlights a new Illinois Medicaid managed‑care contract that adds a multi‑year revenue stream, and analyst upgrades from RBC, Bank of America, and Mizuho that raise price targets and signal optimism about reimbursement rates and regulatory conditions; these developments suggest short‑term momentum could be supported by the contract and margin outlook. Investors should watch for the Q2 2026 earnings release scheduled for July 22, 2026, to confirm margin improvements and the financial impact of the Illinois deal, as well as any updates on Medicaid reimbursement rates or optional extension clauses that could affect the durability of the new revenue stream.}}

Read full report

EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$1.45	-	-
Q1'26	$1.94	$2.35	+21.4%
Q4'25	$0.34	$-2.75	-916.0%
Q3'25	$3.89	$1.84	-52.7%
Q2'25	$5.53	$5.48	-0.9%
Q1'25	$5.96	$6.08	+2.1%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$10.9B	-	-
Q1'26	$10.9B	$10.8B	-0.8%
Q4'25	$11.0B	$11.4B	+3.7%
Q3'25	-	$11.5B	-
Q2'25	-	$11.4B	-
Q1'25	-	$11.1B	-

Full Earnings BreakdownEstimates, actuals, guidance, and historical context

→

Market Data

MOH Stock Snapshot

MOH is currently trading at $201.00, giving Molina Healthcare, Inc. a market cap of 10.12B and a P/E ratio of 53.8. Today's range spans $192.50–$204.54, with shares opening at $197.00 and moving down $0.56 (0.3%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 57/100.

Over the past year MOH has traded between $121.06 and $311.52 - the current price is +66.0% off the 52-week low and -35.5% from the high. 25 analysts cover the stock with a Hold consensus and a mean 12-month target of $191.76 (range $129.00–$262.00), implying downside of -4.6%.

The Healthcare sector has plenty of names, but MOH is one of the few right now where technical and sentiment data are both bullish. Score: 82/100 (BUY). Sentiment: neutral (57/100). Price: $201.00 (in the lower half of its 52-week range). The current P/E ratio stands at 53.8. With 10.12B in market cap, this is the scale where fundamental thesis and technical setup reinforce rather than compete with each other. Annual range: $121.06–$311.52.

Earnings revision cycles in large-cap Healthcare names tend to compound: when technicals confirm a BUY thesis (82/100) and news sentiment (57/100, neutral) supports the narrative, analyst upgrades follow price rather than lead it. At $201.00 (in the lower half of its 52-week range), MOH's position within the $121.06–$311.52 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.

News Sentiment Analysis

Sentiment gathered from recent headlines

57/100

Strong NegativeNeutralStrong Positive

MODERATELY BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

RBC Capital has begun coverage of Molina Healthcare, issuing a sector perform recommendation. The brokerage signals confidence in the company’s current business model and potential upside. This move may influence investor perception and could prompt a review of the stock’s valuation. Traders should note the new coverage as a potential catalyst for price movement.

What did this article say?

Argus Research has lowered its valuation target for MOH to $206, reflecting a more cautious outlook on the company’s earnings trajectory. The downgrade signals that analysts expect tighter margins and slower revenue growth than previously projected. This adjustment may increase pressure on MOH’s share price as investors reassess the firm’s profitability prospects. The change underscores the need for investors to monitor the company’s upcoming earnings report for further guidance on revenue and cost dynamics.

What did this article say?

RBC analysts confirm that Molina Healthcare (MOH) has a clear earnings‑growth trajectory through 2027, even as Medicaid reimbursement rates remain a concern. The company’s near‑term path is deemed visible, with expected revenue expansion driven by its managed‑care contracts. Investors should monitor Medicaid rate adjustments and the company’s forthcoming earnings guidance for any shifts in the growth outlook.

What did this article say?

RBC has initiated coverage on Molina Healthcare (MOH) with a sector perform rating and a $216 price target. The brokerage noted the company’s current average rating of hold and mean price target of $187.41. The new target reflects expectations of improved earnings and market positioning. Traders should monitor upcoming earnings releases and regulatory developments that could influence the valuation.

What did this article say?

RBC Capital has initiated coverage on Molina Healthcare (MOH) with a Sector Perform rating and a $216 price target, signaling a bullish stance relative to peers. The rating suggests the company is expected to outperform its sector, while the target reflects confidence in its growth prospects. Traders should watch for RBC’s detailed earnings forecast and any subsequent adjustments to the price target.

What did this article say?

Over the past six months, Molina Healthcare (MOH) has outperformed the S&P 500 by 10.8%, with its share price rising 23.2% to $200. The company’s five‑year sales CAGR of 16.2% exceeds the average for the healthcare sector, indicating robust demand for its Medicaid and Medicare services. Economies of scale give MOH leverage in supplier negotiations, potentially improving margins. While the recent rally reflects investor enthusiasm, analysts advise monitoring earnings guidance and regulatory developments for potential headwinds.

What did this article say?

Molina Healthcare secured a new HealthChoice Illinois Medicaid Managed Care contract, boosting short‑term momentum. Q1 2026 margin projections have improved, supporting the company’s earnings outlook. A recent Bank of America upgrade has heightened investor interest and lifted the stock above its average analyst price target. Despite a 36.7% 90‑day share price return, the one‑year total shareholder return remains down 32.8%, indicating a potential long‑term valuation concern.

What did this article say?

Mizuho lifted its price target for Molina Healthcare (MOH) to $215 from $200, maintaining an Outperform rating. The upgrade follows a view that the managed‑care sector will experience a more stable policy environment, reducing surprise regulatory impacts. Molina’s investor day highlighted a projected 14% premium growth to ~$48 B in 2027, driven by embedded revenue. Traders should monitor upcoming earnings releases and any changes in Medicaid/Medicare reimbursement rates.

What did this article say?

Molina Healthcare has secured a new Medicaid managed‑care contract in Illinois, expected to commence on January 1, 2027. The four‑and‑a‑half‑year agreement, with optional extensions, will position the company as one of six plans covering roughly 3.1 million beneficiaries. The deal expands MOH’s footprint in a key state market, potentially increasing revenue streams and enhancing scale. Traders should monitor the contract’s performance metrics and any subsequent renewal negotiations. The announcement may also influence MOH’s earnings guidance for the upcoming fiscal year.

What did this article say?

Molina Healthcare announced that the Illinois Department of Healthcare and Family Services will award its HealthChoice Illinois Medicaid Managed Care program to the company’s Illinois subsidiary. The contract will begin on January 1, 2027, and is slated for a four‑and‑a‑half‑year term, with a five‑and‑a‑half‑year extension option. This partnership places MOH among six providers serving about 3.1 million Medicaid beneficiaries, potentially boosting the firm’s revenue base and market share. Investors should watch for the first‑quarter performance of the Illinois plan and any updates on the extension clause. The deal may also affect MOH’s projected earnings for FY2027.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

MOH·Molina Healthcare, Inc.

EPS

Revenue

MOH Stock Snapshot

News Sentiment Analysis

Recent News Coverage

Discover More

News Sentiment Analysis

Recent News Coverage

Discover More